Clinical Trial: A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping

U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07511114) titled 'A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping' on March 03.

Brief Summary: Evaluate the efficacy and safety of C Pola R-CHP+X compared to CR-CHOP in the treatment of previously untreated patients with DEL

Study Start Date: March 31

Study Type: INTERVENTIONAL

Condition: DLBCL - Diffuse Large B Cell Lymphoma Double Expressor Lymphoma

Intervention: DRUG: C-Pola-R-CHP+X

The experimental group first received one course of CR-CHOP regimen, and then the subsequent treatment was determined based on whether the ctDNA LFC reached 3 after one cycle of CR-CHOP ...